RTX Corp: Form 10-Q for the period ended Mar 31, 2018
Filed with the SEC on Apr 27, 2018 and accepted by EDGAR at Apr 27, 2018, 06:45 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2018-01-01 to 2018-03-31 | $8.02bn | us-gaap:CostOfGoodsSold |
| Research and development | 3 months2018-01-01 to 2018-03-31 | $554.0m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2018-01-01 to 2018-03-31 | $1.71bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2018-01-01 to 2018-03-31 | $1.93bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2018-01-01 to 2018-03-31 | $229.0m | us-gaap:InterestExpense |
| Income tax | 3 months2018-01-01 to 2018-03-31 | $522.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-01-01 to 2018-03-31 | $1.30bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2018-01-01 to 2018-03-31 | $1.62 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2018-01-01 to 2018-03-31 | $1.64 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2018-01-01 to 2018-03-31 | 800,400,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2018-01-01 to 2018-03-31 | $453.0m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 3 months2018-01-01 to 2018-03-31 | $337.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 3 months2018-01-01 to 2018-03-31 | $535.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2018-01-01 to 2018-03-31 | $25.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2018-03-31 | $7.67bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-03-31 | $32.74bn | us-gaap:AssetsCurrent |
| Total assets | At period end2018-03-31 | $98.78bn | us-gaap:Assets |
| Current liabilities | At period end2018-03-31 | $24.75bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-03-31 | $66.15bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2018-03-31 | $1.07bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2018-03-31 | $30.53bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2018-03-31 | 800,059,478 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000101829-18-000009. Last ingested by Listed: Nov 3, 2026, 21:25 ET. Listed shows no prices and gives no investment advice.